Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZNCF) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Astrazeneca (AZNCF) over the last 17 years, with Q4 2025 value amounting to 0.34.

  • Astrazeneca's Debt Ratio fell 576.17% to 0.34 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.34, marking a year-over-year decrease of 576.17%. This contributed to the annual value of 0.34 for FY2025, which is 576.17% down from last year.
  • Astrazeneca's Debt Ratio amounted to 0.34 in Q4 2025, which was down 576.17% from 0.36 recorded in Q3 2025.
  • Astrazeneca's Debt Ratio's 5-year high stood at 286.48 during Q4 2021, with a 5-year trough of 0.44 in Q1 2021.
  • Over the past 5 years, Astrazeneca's median Debt Ratio value was 0.35 (recorded in 2025), while the average stood at 14.06.
  • As far as peak fluctuations go, Astrazeneca's Debt Ratio surged by 5773212.32% in 2021, and later tumbled by 21652.41% in 2024.
  • Quarter analysis of 5 years shows Astrazeneca's Debt Ratio stood at 286.48 in 2021, then plummeted by 99.9% to 0.29 in 2022, then decreased by 7.23% to 0.27 in 2023, then crashed by 216.52% to 0.32 in 2024, then dropped by 5.76% to 0.34 in 2025.
  • Its last three reported values are 0.34 in Q4 2025, 0.36 for Q3 2025, and 0.22 during Q2 2025.